BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24249259)

  • 1. Inactivation of the tumor suppressor WTX in a subset of pediatric tumors.
    Akhavanfard S; Vargas SO; Han M; Nitta M; Chang CB; Le LP; Fazlollahi L; Nguyen Q; Ma Y; Cosper A; Dias-Santagata D; Han JY; Bergethon K; Borger DR; Ellisen LW; Pomeroy SL; Haber DA; Iafrate AJ; Rivera MN
    Genes Chromosomes Cancer; 2014 Jan; 53(1):67-77. PubMed ID: 24249259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and analysis of mutations in WTX and WT1 genes in peripheral blood and tumor tissue of children with Wilms' tumor.
    Wang H; Shen Y; Sun N; Jiang YP; Li ML; Sun L
    Chin Med J (Engl); 2012 May; 125(10):1733-9. PubMed ID: 22800892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors.
    Ruteshouser EC; Robinson SM; Huff V
    Genes Chromosomes Cancer; 2008 Jun; 47(6):461-70. PubMed ID: 18311776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WTX inactivation is a frequent, but late event in Wilms tumors without apparent clinical impact.
    Wegert J; Wittmann S; Leuschner I; Geissinger E; Graf N; Gessler M
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1102-11. PubMed ID: 19760609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An X chromosome gene, WTX, is commonly inactivated in Wilms tumor.
    Rivera MN; Kim WJ; Wells J; Driscoll DR; Brannigan BW; Han M; Kim JC; Feinberg AP; Gerald WL; Vargas SO; Chin L; Iafrate AJ; Bell DW; Haber DA
    Science; 2007 Feb; 315(5812):642-5. PubMed ID: 17204608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical, Pathologic, and Genetic Features of Wilms Tumors With WTX Gene Mutation.
    Alexandrescu S; Akhavanfard S; Harris MH; Vargas SO
    Pediatr Dev Pathol; 2017; 20(2):105-111. PubMed ID: 28326956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WT1, WTX and CTNNB1 mutation analysis in 43 patients with sporadic Wilms' tumor.
    Cardoso LC; De Souza KR; De O Reis AH; Andrade RC; Britto AC; De Lima MA; Dos Santos AC; De Faria PS; Ferman S; Seuánez HN; Vargas FR
    Oncol Rep; 2013 Jan; 29(1):315-20. PubMed ID: 23117548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional inactivation of the WTX gene is not a frequent event in Wilms' tumors.
    Perotti D; Gamba B; Sardella M; Spreafico F; Terenziani M; Collini P; Pession A; Nantron M; Fossati-Bellani F; Radice P
    Oncogene; 2008 Jul; 27(33):4625-32. PubMed ID: 18391980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wilms' tumor with an apparently balanced translocation t(X;18) resulting in deletion of the WTX gene.
    Han M; Rivera MN; Batten JM; Haber DA; Dal Cin P; Iafrate AJ
    Genes Chromosomes Cancer; 2007 Oct; 46(10):909-13. PubMed ID: 17620295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel WTX mutation in a female patient with osteopathia striata with cranial sclerosis and hepatoblastoma.
    Fujita A; Ochi N; Fujimaki H; Muramatsu H; Takahashi Y; Natsume J; Kojima S; Nakashima M; Tsurusaki Y; Saitsu H; Matsumoto N; Miyake N
    Am J Med Genet A; 2014 Apr; 164A(4):998-1002. PubMed ID: 24459086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canonical WNT signalling determines lineage specificity in Wilms tumour.
    Fukuzawa R; Anaka MR; Weeks RJ; Morison IM; Reeve AE
    Oncogene; 2009 Feb; 28(8):1063-75. PubMed ID: 19137020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The General Expression Analysis of WTX Gene in Normal and Cancer Tissues.
    Zhang YY; Wang QM; Niu HL; Liu X; Zhang QL
    Pathol Oncol Res; 2017 Apr; 23(2):439-446. PubMed ID: 28032309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Wilms tumor 1 gene in a variety of pediatric tumors.
    Oue T; Uehara S; Yamanaka H; Takama Y; Oji Y; Fukuzawa M
    J Pediatr Surg; 2011 Dec; 46(12):2233-8. PubMed ID: 22152856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different incidences of epigenetic but not genetic abnormalities between Wilms tumors in Japanese and Caucasian children.
    Haruta M; Arai Y; Watanabe N; Fujiwara Y; Honda S; Ohshima J; Kasai F; Nakadate H; Horie H; Okita H; Hata J; Fukuzawa M; Kaneko Y
    Cancer Sci; 2012 Jun; 103(6):1129-35. PubMed ID: 22409817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of Wilms tumor-suppressor WTX and tumor-associated mutants.
    Kim MK; Min DJ; Rabin M; Licht JD
    Oncogene; 2011 Feb; 30(7):832-42. PubMed ID: 20956941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of p53 gene in childhood malignant solid tumors.
    Kusafuka T; Fukuzawa M; Oue T; Komoto Y; Yoneda A; Okada A
    J Pediatr Surg; 1997 Aug; 32(8):1175-80. PubMed ID: 9269965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of WTX gene in Wnt/ beta-catenin pathway in gastric, colorectal, and hepatocellular carcinomas.
    Yoo NJ; Kim S; Lee SH
    Dig Dis Sci; 2009 May; 54(5):1011-4. PubMed ID: 18720004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WTX mutations can occur both early and late in the pathogenesis of Wilms tumour.
    Fukuzawa R; Holman SK; Chow CW; Savarirayan R; Reeve AE; Robertson SP
    J Med Genet; 2010 Nov; 47(11):791-4. PubMed ID: 20679664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wilms tumor gene on X chromosome (WTX) inhibits degradation of NRF2 protein through competitive binding to KEAP1 protein.
    Camp ND; James RG; Dawson DW; Yan F; Davison JM; Houck SA; Tang X; Zheng N; Major MB; Moon RT
    J Biol Chem; 2012 Feb; 287(9):6539-50. PubMed ID: 22215675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is predisposition for nephroblastoma linked to polymorphisms of the WTX gene?
    Guertl B; Leuschner I; Guelly C; Ebner B; Kronberger C; Hoefler G
    Pathol Oncol Res; 2010 Jun; 16(2):189-91. PubMed ID: 19757195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.